Massimiliano Camilli

2.0k total citations · 3 hit papers
77 papers, 1.2k citations indexed

About

Massimiliano Camilli is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Massimiliano Camilli has authored 77 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Cardiology and Cardiovascular Medicine, 24 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Surgery. Recurrent topics in Massimiliano Camilli's work include Chemotherapy-induced cardiotoxicity and mitigation (24 papers), Cardiac Imaging and Diagnostics (22 papers) and Cardiovascular Function and Risk Factors (16 papers). Massimiliano Camilli is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (24 papers), Cardiac Imaging and Diagnostics (22 papers) and Cardiovascular Function and Risk Factors (16 papers). Massimiliano Camilli collaborates with scholars based in Italy, Japan and United States. Massimiliano Camilli's co-authors include Filippo Crea, Marco Giuseppe Del Buono, Rocco Antonio Montone, Giampaolo Niccoli, Carl J. Lavie, Salvatore Carbone, Jagat Narula, Giulia Iannaccone, Giorgio Minotti and Carlo Trani and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Massimiliano Camilli

64 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases

2021 340 citations Marco Giuseppe Del Buono, Rocco Antonio Montone et al. profile →
Anthracycline Cardiotoxicity in Adult Cancer Patients

2024 54 citations Massimiliano Camilli, Giorgio Minotti et al. profile →
Exposome in ischaemic heart disease: beyond traditional risk factors

2024 43 citations Rocco Antonio Montone, Massimiliano Camilli et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimiliano Camilli Italy	17	774	402	297	131	124	77	1.2k
Takahisa Sawada Japan	19	661 0.9×	244 0.6×	447 1.5×	62 0.5×	186 1.5×	123	1.3k
Mattía Galli Italy	22	1.4k 1.9×	240 0.6×	689 2.3×	54 0.4×	103 0.8×	138	1.9k
Giulia Iannaccone Italy	13	285 0.4×	133 0.3×	120 0.4×	37 0.3×	81 0.7×	53	570
Kazuteru Fujimoto Japan	15	626 0.8×	258 0.6×	256 0.9×	35 0.3×	109 0.9×	36	1.1k
Taylan Akgün Türkiye	21	691 0.9×	115 0.3×	305 1.0×	79 0.6×	160 1.3×	78	1.1k
İbrahіm Özdoğru Türkiye	21	1.2k 1.5×	237 0.6×	179 0.6×	525 4.0×	334 2.7×	80	1.8k
Enrique Gutiérrez Spain	20	741 1.0×	240 0.6×	367 1.2×	119 0.9×	227 1.8×	82	1.2k
İdris Ardıç Türkiye	18	668 0.9×	126 0.3×	155 0.5×	401 3.1×	159 1.3×	54	1.1k
Takumi Higuma Japan	18	697 0.9×	388 1.0×	538 1.8×	16 0.1×	152 1.2×	81	1.1k
Yingling Zhou China	18	248 0.3×	141 0.4×	158 0.5×	43 0.3×	175 1.4×	70	899

Countries citing papers authored by Massimiliano Camilli

Since Specialization

Citations

This map shows the geographic impact of Massimiliano Camilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimiliano Camilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimiliano Camilli more than expected).

Fields of papers citing papers by Massimiliano Camilli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimiliano Camilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimiliano Camilli. The network helps show where Massimiliano Camilli may publish in the future.

Co-authorship network of co-authors of Massimiliano Camilli

This figure shows the co-authorship network connecting the top 25 collaborators of Massimiliano Camilli. A scholar is included among the top collaborators of Massimiliano Camilli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimiliano Camilli. Massimiliano Camilli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Minotti, Giorgio, Massimiliano Camilli, Emanuela Salvatorelli, & Pierantonio Menna. (2025). Advances in Bruton tyrosine kinase (Btk) inhibition are steered by Bruton tyrosine kinase phylogeny. British Journal of Pharmacology. 182(7). 1446–1451.

Camilli, Massimiliano, Luca Maggio, Lorenzo Tinti, et al.. (2025). Cardio-oncology: Emerging Concepts in Cardiovascular Sequelae of Cancer Therapies, Translational Research and Reverse Cardio-oncology. European Cardiology Review. 20. e05–e05. 1 indexed citations

Camilli, Massimiliano, Lucia Leccisotti, Eugenio Galli, et al.. (2025). Vascular inflammation in patients undergoing anti-CD19 chimeric antigen receptor-T cells for haematologic malignancies: a call for cardiovascular surveillance. European Heart Journal. 47(9). 1114–1117.

Vecchia, Giulia La, Giulia Iannaccone, Michele Russo, et al.. (2025). Right ventricular-pulmonary artery coupling assessed by two-dimensional strain predicts in-hospital complications in Takotsubo syndrome. International Journal of Cardiology. 424. 133044–133044.

Camilli, Massimiliano, Valentina A. Rossi, Antonio Cannatà, et al.. (2024). Iron Deficiency and Supplementation in Patients with Heart Failure: Results from the IRON-HF International Survey. European Journal of Heart Failure. 27(1). 140–147. 2 indexed citations

Sayour, Nabil V., Pietro Ameri, Wouter C. Meijers, et al.. (2024). Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence. European Heart Journal. 45(14). 1224–1240. 22 indexed citations

Montone, Rocco Antonio, Massimiliano Camilli, Camilla Calvieri, et al.. (2024). Exposome in ischaemic heart disease: beyond traditional risk factors. European Heart Journal. 45(6). 419–438. 43 indexed citations breakdown →

Camilli, Massimiliano, et al.. (2024). Anthracyclines, Diastolic Dysfunction and the road to Heart Failure in Cancer survivors: An untold story. Progress in Cardiovascular Diseases. 86. 38–47. 5 indexed citations

Galluzzo, Alessandro, Francesca Fiorelli, Valentina A. Rossi, et al.. (2023). Multimodality Imaging in Sarcomeric Hypertrophic Cardiomyopathy: Get It Right…on Time. Life. 13(1). 171–171. 3 indexed citations

10.

Bugani, Giulia, et al.. (2023). Il paziente con trombosi ventricolare sinistra dopo infarto miocardico acuto: tra evidenze disponibili, incertezze e prospettive future. Giornale italiano di cardiologia. 24(3). 196–205. 1 indexed citations

11.

Paccone, Andrea, Chiara Lestuzzi, Maria Laura Canale, et al.. (2023). P173 THERAPEUTIC MANAGEMENT OF FLUOROPYRIMIDINE CARDIOTOXICITY: AN ANECDOTAL CASE. European Heart Journal Supplements. 25(Supplement_D). D107–D107.

12.

Russo, Michele, Riccardo Rinaldi, Massimiliano Camilli, et al.. (2023). Air pollution and plaque healing in acute coronary syndromes. European Heart Journal. 44(26). 2403–2405. 11 indexed citations

13.

Iannaccone, Giulia, Maria Lucia Narducci, Gaetano Pinnacchio, et al.. (2023). Mechanisms, Prevalence and Management of Cardiac Arrhythmias in Cancer Patients: A Comprehensive Review. Future Cardiology. 19(14). 707–718. 1 indexed citations

14.

Iannaccone, Giulia, Francesca Graziani, Marco Giuseppe Del Buono, et al.. (2023). Left atrial strain analysis improves left ventricular filling pressures non-invasive estimation in the acute phase of Takotsubo syndrome. European Heart Journal - Cardiovascular Imaging. 24(6). 699–707. 10 indexed citations

15.

Camilli, Massimiliano, Irma Bisceglia, Maria Laura Canale, et al.. (2022). Sacubitril/valsartan nel paziente oncologico con cardiotossicità: abbiamo una nuova arma nel nostro arsenale terapeutico?. Giornale italiano di cardiologia. 23(4). 278–285. 1 indexed citations

16.

Bisceglia, Irma, Maria Laura Canale, Massimiliano Camilli, et al.. (2022). Cardioncogeriatria: position paper ANMCO sulla gestione cardioncologica del paziente anziano. Giornale italiano di cardiologia. 23(11). 878–891.

17.

Buono, Marco Giuseppe Del, Rocco Antonio Montone, Maria Chiara Meucci, et al.. (2021). Left ventricular end-diastolic pressure predicts in-hospital outcomes in takotsubo syndrome. European Heart Journal Acute Cardiovascular Care. 10(6). 661–667. 15 indexed citations

18.

Montone, Rocco Antonio, Leonarda Galiuto, Maria Chiara Meucci, et al.. (2020). Coronary slow flow is associated with a worse clinical outcome in patients with Takotsubo syndrome. Heart. 106(12). 923–930. 38 indexed citations

19.

Russo, Michele, Rocco Antonio Montone, Domenico D’Amario, et al.. (2020). Role of perilipin 2 in microvascular obstruction in patients with ST-elevation myocardial infarction. European Heart Journal Acute Cardiovascular Care. 10(6). 633–642. 11 indexed citations

20.

Montone, Rocco Antonio, Massimiliano Camilli, Michele Russo, et al.. (2020). Macrophage infiltrates in coronary plaque erosion and cardiovascular outcome in patients with acute coronary syndrome. Atherosclerosis. 311. 158–166. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact